ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.30
0.07%
Dow Jones
44,910.65
0.42%
Gold vs US Dollar
2,649.87
0.00%
Brent Oil
71.98
0.00%
Bitcoin
96,471.36
0.03%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MedTech Acquisition Corporation (MTAC)

  7. MedTech Acquisition Corporation (MTAC) News

MedTech Acquisition (MTAC)

MedTech Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MTAC
DateTimeSourceHeadlineSymbolCompany
02/08/202321:00Business WireMedTech Acquisition Corporation Adjourns Special Meeting of StockholdersNASDAQ:MTACMedTech Acquisition Corporation
27/06/202320:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MTACMedTech Acquisition Corporation
22/06/202321:07Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MTACMedTech Acquisition Corporation
15/06/202321:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
15/06/202320:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202311:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202311:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202311:00Business WireTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingNASDAQ:MTACMedTech Acquisition Corporation
08/06/202311:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
08/06/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
24/05/202320:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MTACMedTech Acquisition Corporation
15/05/202311:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
15/05/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/04/202321:12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202311:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202311:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202311:00Business WireTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesNASDAQ:MTACMedTech Acquisition Corporation
05/04/202320:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
05/04/202320:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
22/03/202320:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MTACMedTech Acquisition Corporation
08/03/202321:34Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
08/03/202321:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202312:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202312:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202312:00Business WireTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessNASDAQ:MTACMedTech Acquisition Corporation
16/02/202312:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
16/02/202312:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
09/02/202322:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
09/02/202314:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
08/02/202319:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:MTAC

Your Recent History

LSE
ALBA
Alba Mineral Resources
LSE
BOO
Boohoo
LSE
SPX
Spirax
LSE
RKH
Rockhopper Exploration
LSE
LGRS
Loungers
LSE
EDEN
Eden Research
LSE
XPF
Xp Factory
LSE
APTA
Aptamer
LSE
VAL
Valirx
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Silver

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £903.96 only £451.98